Coverart for item
The Resource Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa, (electronic book)

Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa, (electronic book)

Label
Anticoagulants, antiplatelets, and thrombolytics
Title
Anticoagulants, antiplatelets, and thrombolytics
Statement of responsibility
edited by Shaker A. Mousa
Contributor
Subject
Language
eng
Summary
During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic. Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition provides updates on various strategies in thrombosis, experimental models, and clinical and recent advances in the discovery and development of novel antithrombotics. As a volume in the highly successful Methods in Molecular Biology series, this collection provides the kind of detailed description and implementation advice that is crucial for getting optimal results. Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the prevention of thromboembolic disorders and the protection of the vascular endothelium
Member of
Cataloging source
SCB
Dewey number
615/.718
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
Mousa, Shaker A
http://library.link/vocab/subjectName
  • Anticoagulants (Medicine)
  • Blood platelets
  • Thrombolytic therapy
  • Fibrinolytic agents
  • Anticoagulants
  • Thrombolytic Therapy
  • Fibrinolytic Agents
  • Heparin
  • Platelet Aggregation Inhibitors
  • Thrombocytopenia
Label
Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa, (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Contents
In vitro methods of evaluating antithrombotics and thrombolytics / S.A. Mousa -- In vivo models for the evaluation of antithrombotics and thrombolytics / S.A. Mousa -- Heparin and low-molecular weight heparins in thrombosis and beyond / S.A. Mousa -- Laboratory methods and management of patients with heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Novel anticoagulant therapy: Principle and practice / S.A. Mousa -- Oral direct factor xa inhibitors, with special emphasis on rivaroxaban / S.A. Mousa -- Antiplatelet therapies: Drug interactions in the management of vascular disorders / S.A. Mousa -- Prasugrel: A novel platelet adp p2y(12) receptor antagonist / S.A. Mousa, W.P. Jeske and J. Fareed -- Antithrombotic effects of naturally derived products on coagulation and platelet function / S.A. Mousa -- Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis / A. Amirkhosravi ... [et al.] -- Adhesion molecules: Potential therapeutic and diagnostic implications / S.A. Mousa -- Pharmacogenomics in thrombosis / S.A. Mousa -- Diagnosis and management of sickle cell disorders / S.A. Mousa and M.H. Qari
Control code
SPR650900228
Dimensions
unknown
Edition
2nd ed.
Extent
xi, 316 p.
Form of item
online
Isbn
9781607618027
Other physical details
ill.
Specific material designation
remote
Label
Anticoagulants, antiplatelets, and thrombolytics, edited by Shaker A. Mousa, (electronic book)
Publication
Bibliography note
Includes bibliographical references and index
Contents
In vitro methods of evaluating antithrombotics and thrombolytics / S.A. Mousa -- In vivo models for the evaluation of antithrombotics and thrombolytics / S.A. Mousa -- Heparin and low-molecular weight heparins in thrombosis and beyond / S.A. Mousa -- Laboratory methods and management of patients with heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Novel anticoagulant therapy: Principle and practice / S.A. Mousa -- Oral direct factor xa inhibitors, with special emphasis on rivaroxaban / S.A. Mousa -- Antiplatelet therapies: Drug interactions in the management of vascular disorders / S.A. Mousa -- Prasugrel: A novel platelet adp p2y(12) receptor antagonist / S.A. Mousa, W.P. Jeske and J. Fareed -- Antithrombotic effects of naturally derived products on coagulation and platelet function / S.A. Mousa -- Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis / A. Amirkhosravi ... [et al.] -- Adhesion molecules: Potential therapeutic and diagnostic implications / S.A. Mousa -- Pharmacogenomics in thrombosis / S.A. Mousa -- Diagnosis and management of sickle cell disorders / S.A. Mousa and M.H. Qari
Control code
SPR650900228
Dimensions
unknown
Edition
2nd ed.
Extent
xi, 316 p.
Form of item
online
Isbn
9781607618027
Other physical details
ill.
Specific material designation
remote

Library Locations

Processing Feedback ...